Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach

被引:63
作者
AbdulHameed, Mohamed Diwan M. [1 ]
Chaudhury, Sidhartha [1 ]
Singh, Narender [1 ]
Sun, Hongmao [1 ]
Wallqvist, Anders [1 ]
Tawa, Gregory J. [1 ]
机构
[1] USA, Biotechnol High Performance Comp Software Applica, Telemed & Adv Technol Res Ctr, Med Res & Mat Command, Ft Detrick, MD 21702 USA
关键词
LIGAND-BASED APPROACH; LONG-QT-SYNDROME; DRUG DISCOVERY; PHARMACOLOGY; INHIBITORS; DOCKING; SERVER; SPACE; RATES; 2D;
D O I
10.1021/ci2003544
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polypharmacology has emerged as a new theme in drug discovery. In this paper, we studied polypharmacology using a ligand-based target fishing (LBTF) protocol. To implement the protocol, we first generated a chemogenomic database that links individual protein targets with a specified set of drugs or target representatives. Target profiles were then generated for a given query molecule by computing maximal shape/chemistry overlap between the query molecule and the drug sets assigned to each protein target. The overlap was computed using the program ROCS (Rapid Overlay of Chemical Structures). We validated this approach using the Directory of Useful Decoys (DUD). DUD contains 2950 active compounds, each with 36 property-matched decoys, against 40 protein targets. We chose a set of known drugs to represent each DUD target, and we carried out ligand-based virtual screens using data sets of DUD actives seeded into DUD decoys for each target. We computed Receiver Operator Characteristic (ROC) curves and associated area under the curve (AUC) values. For the majority of targets studied, the AUC values were significantly better than for the case of a random selection of compounds. In a second test, the method successfully identified off-targets for drugs such as rimantadine, propranolol, and domperidone that were consistent with those identified by recent experiments. The results from our ROCS-based target fishing approach are promising and have potential application in drug repurposing for single and multiple targets, identifying targets for orphan compounds, and adverse effect prediction.
引用
收藏
页码:492 / 505
页数:14
相关论文
共 54 条
  • [1] [Anonymous], 2009, ROCS 3 0 0
  • [2] [Anonymous], Search
  • [3] [Anonymous], 2010, FILT 2 1 0
  • [4] [Anonymous], 2010, OMEGA 2 4 1
  • [5] Drug repositioning: Identifying and developing new uses for existing drugs
    Ashburn, TT
    Thor, KB
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 673 - 683
  • [6] Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle
    Cardelús, I
    Antón, F
    Beleta, J
    Palacios, JM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 374 (02) : 249 - 254
  • [7] Dual Inhibitors of Phosphodiesterase-4 and Serotonin Reuptake
    Cashman, John R.
    Voelker, Troy
    Zhang, Han-Ting
    O'Donnell, James M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (06) : 1530 - 1539
  • [8] Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers
    Cavalli, A
    Poluzzi, E
    De Ponti, F
    Recanatini, M
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) : 3844 - 3853
  • [9] Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO
  • [10] 2-G